Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

10 treatments under study, led by Ropivacaine

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

83%

5 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

6Total
Phase 2 (1)
Phase 4 (5)

Trial Status

Completed4
Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Ropivacaine2
  • Intraoperative Analgesia1
  • The Dr Group1
  • The R Group1
  • Dexmedetomidine1

Active Sponsors

  • Beijing Tiantan Hospital3
  • Tanta University1
  • University of Debrecen1

Top Investigators

  • Beijing Tiantan Hospital

  • Beijing Tiantan Hospital

  • University of Debrecen Medical and Health Science Center Department of Anesthesiology and Intensive Care 4032-Debrecen, Nagyerdei krt 98. Hungary Tel/fax: +36-52-255-347

Related Conditions

  • Pain Postoperative3
  • Postoperative Complications1
  • Intraoperative Analgesic Use1
  • Postoperative Analgesic Use1

Activity Timeline